References
Bednar I., Paterson D., Marutle A., Pham T., Svedberg M., Hellstrom E., et al. (2002) Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Mol. Cell. Neurosci. 20, 354–365.
Chu L. W., Ma E. S., Lam K. K., Chan M. F., and Lee D. H. (2005) Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 19, 106–112.
Dineley K., Westerman M., Bui D., Bell K., Ashe K., and Sweatt J. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125–4133.
Hellstrom E., Court J., Keverne J., Svedberg M., Lee M., Marutle A., et al., (2004) Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur. J. Neurosci. 19, 2703–2710.
Jones I. W., Barik J., O'Neill M. J., and Wonnacott S. (2004) Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors. J. Neurosci. Methods 134, 65–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jones, I.W., Westmacott, A., Chan, E. et al. α7 nicotinic acetylcholine receptor expression in Alzheimer's disease. J Mol Neurosci 30, 83–84 (2006). https://doi.org/10.1385/JMN:30:1:83
Issue Date:
DOI: https://doi.org/10.1385/JMN:30:1:83